Bio­gen makes a buy­out deal, but it’s not the big one you’ve been wait­ing for

The cat­a­lyst junkies have been buzzing for days about the pos­si­bil­i­ty that Bio­gen would use its Q4 re­port Thurs­day to fire off a long an­tic­i­pat­ed …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.